Kéri G - Search Results

1

Comparison of predictive ability of water solubility QSPR models generated by MLR, PLS and ANN methods.

Erös D, Kéri G, Kövesdi I, Szántai-Kis C, Mészáros G, Orfi L. Erös D, et al. Among authors: keri g. Mini Rev Med Chem. 2004 Feb;4(2):167-77. doi: 10.2174/1389557043487466. Mini Rev Med Chem. 2004. PMID: 14965289

2

Validation subset selections for extrapolation oriented QSPAR models.

Szántai-Kis C, Kövesdi I, Kéri G, Orfi L. Szántai-Kis C, et al. Among authors: keri g. Mol Divers. 2003;7(1):37-43. doi: 10.1023/b:modi.0000006538.99122.00. Mol Divers. 2003. PMID: 14768902

3

Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.

Székelyhidi Z, Pató J, Wáczek F, Bánhegyi P, Hegymegi-Barakonyi B, Erös D, Mészáros G, Hollósy F, Hafenbradl D, Obert S, Klebl B, Kéri G, Orfi L. Székelyhidi Z, et al. Among authors: keri g. Bioorg Med Chem Lett. 2005 Jul 1;15(13):3241-6. doi: 10.1016/j.bmcl.2005.04.064. Bioorg Med Chem Lett. 2005. PMID: 15925511

4

Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.

Kéri G, Székelyhidi Z, Bánhegyi P, Varga Z, Hegymegi-Barakonyi B, Szántai-Kis C, Hafenbradl D, Klebl B, Muller G, Ullrich A, Erös D, Horváth Z, Greff Z, Marosfalvi J, Pató J, Szabadkai I, Szilágyi I, Szegedi Z, Varga I, Wáczek F, Orfi L. Kéri G, et al. Assay Drug Dev Technol. 2005 Oct;3(5):543-51. doi: 10.1089/adt.2005.3.543. Assay Drug Dev Technol. 2005. PMID: 16305311 Review.

5

[Application of Kohonen Self-Organizing Feature Maps in QSAR of human ADMET and kinase data sets].

Hegymegi-Barakonyi B, Orfi L, Kéri G, Kövesdi I. Hegymegi-Barakonyi B, et al. Among authors: keri g. Acta Pharm Hung. 2013;83(4):143-8. Acta Pharm Hung. 2013. PMID: 24575660 Hungarian.

6

Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.

Garamvölgyi R, Dobos J, Sipos A, Boros S, Illyés E, Baska F, Kékesi L, Szabadkai I, Szántai-Kis C, Kéri G, Őrfi L. Garamvölgyi R, et al. Among authors: keri g. Eur J Med Chem. 2016 Jan 27;108:623-643. doi: 10.1016/j.ejmech.2015.12.001. Epub 2015 Dec 12. Eur J Med Chem. 2016. PMID: 26724730

7

Evaluation of lipophilicity and antitumour activity of parallel carboxamide libraries.

Hollósy F, Seprödi J, Orfi L, Erös D, Kéri G, Idei M. Hollósy F, et al. Among authors: keri g. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 25;780(2):355-63. doi: 10.1016/s1570-0232(02)00545-7. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12401362

8

Improved, high yield synthesis of 3H-quinazolin-4-ones, the key intermediates of recently developed drugs.

Orfi L, Wáczek F, Pató J, Varga I, Hegymegi-Barakonyi B, Houghten RA, Kéri G. Orfi L, et al. Among authors: keri g. Curr Med Chem. 2004 Oct;11(19):2549-53. doi: 10.2174/0929867043364423. Curr Med Chem. 2004. PMID: 15544462

9

Acid-base profiling of imatinib (gleevec) and its fragments.

Szakács Z, Béni S, Varga Z, Orfi L, Kéri G, Noszál B. Szakács Z, et al. Among authors: keri g. J Med Chem. 2005 Jan 13;48(1):249-55. doi: 10.1021/jm049546c. J Med Chem. 2005. PMID: 15634018

10

Lipophilicity and antiproliferative activity profiling of 2-benzylidencycloalkanones.

Hallgas B, Dobos Z, Agócs A, Idei M, Kéri G, Loránd T, Mészáros G. Hallgas B, et al. Among authors: keri g. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 1;856(1-2):148-55. doi: 10.1016/j.jchromb.2007.05.027. Epub 2007 Jun 2. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17644496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters